Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0345904 (
liver cancer
)
15,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Liver organogenesis and cancerogenesis share common mechanisms. HOX genes control normal development, primary cellular processes and are characterized by a unique genomic network organization. Less is known about the involvement of HOX genes with liver cancerogenesis. The comparison of the HOX gene network expression between nontumorous livers and hepatocellular carcinomas (HCCs) highlights significant differences in the locus A HOX genes, located on chromosome 7, with a consistent overexpression of
HOXA13
mRNA thus validating this gene deregulation as a feature of HCC.
HOXA13
is a determinant of gut primordia and posterior body structures. Transcriptome analysis of HCC/nontumorous liver mRNAs, selected on the basis of
HOXA13
overexpression, recognizes a set of deregulated genes. The matching of these genes with previously reported HCC transcriptome analysis identifies cell-cycle and nuclear pore-related HCC phenotype displaying poor prognosis.
HOXA13
and HOXA7 homeoproteins share a consensus sequence that physically links eIF4E nuclear bodies acting on the export of specific mRNAs (c-myc, FGF-2, vascular endothelial growth factor (VEGF), ornithine decarboxylase (ODC) and cyclin D1). We report the protein-protein interaction between
HOXA13
and eIF4E in
liver cancer
cells and the deregulation of eIF4E mRNA and protein in cell cycle/nuclear pore HCC group phenotype and in T4 stage HCCs, respectively. Thus, transcriptional and post-transcriptional
HOXA13
deregulation is involved in HCC possibly through the mRNA nuclear export of eIF4E-dependent transcripts.
...
PMID:The HOX gene network in hepatocellular carcinoma. 2162 5
HOTTIP is a long non-coding RNA (lncRNA) transcribed from the 5' tip of the HOXA locus and is associated with the polycomb repressor complex 2 (PRC2) and WD repeat containing protein 5 (WDR5)/mixed lineage leukemia 1 (MLL1) chromatin modifying complexes. HOTTIP is expressed in pancreatic cancer cell lines and knockdown of HOTTIP by RNA interference (siHOTTIP) in Panc1 pancreatic cancer cells decreased proliferation, induced apoptosis and decreased migration. In Panc1 cells transfected with siHOTTIP, there was a decrease in expression of 757 genes and increased expression of 514 genes, and a limited gene analysis indicated that HOTTIP regulation of genes is complex. For example, Aurora kinase A, an important regulator of cell growth, is coregulated by MLL and not WDR5 and, in contrast to previous studies in
liver cancer
cells, HOTTIP does not regulate
HOXA13
but plays a role in regulation of several other HOX genes including HOXA10, HOXB2, HOXA11, HOXA9 and HOXA1. Although HOTTIP and the HOX-associated lncRNA HOTAIR have similar pro-oncogenic functions, they regulate strikingly different sets of genes in Panc1 cells and in pancreatic tumors.
...
PMID:The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. 2591 6
Hepatocellular carcinoma (HCC) represents the fifth and ninth cause of mortality among male and female cancer patients, respectively and typically arises on a background of a cirrhotic liver. HCC develops in a multi-step process, often encompassing chronic liver injury, steatosis and cirrhosis eventually leading to the malignant transformation of hepatocytes. Aberrant expression of the class I homeobox gene family (HOX), a group of genes crucial in embryogenesis, has been reported in a variety of malignancies including solid tumors. Among HOX genes,
HOXA13
is most overexpressed in HCC and is known to be directly regulated by the long non-coding RNA HOTTIP. In this study, taking advantage of a tissue microarray containing 305 tissue specimens, we found that
HOXA13
protein expression increased monotonically from normal liver to cirrhotic liver to HCC and that
HOXA13
-positive HCCs were preferentially poorly differentiated and had fewer E-cadherin-positive cells. In two independent cohorts, patients with
HOXA13
-positive HCC had worse overall survival than those with
HOXA13
-negative HCC. Using
HOXA13
immunohistochemistry and HOTTIP RNA in situ hybridization on consecutive sections of 16 resected HCCs, we demonstrated that
HOXA13
and HOTTIP were expressed in the same neoplastic hepatocyte populations. Stable overexpression of
HOXA13
in
liver cancer
cell lines resulted in increased colony formation on soft agar and migration potential as well as reduced sensitivity to sorafenib in vitro. Our results provide compelling evidence of a role for
HOXA13
in HCC development and highlight for the first time its ability to modulate response to sorafenib.
...
PMID:High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models. 2903 81
LncRNAs have been associated with infection and hepatitis B virus (HBV)-related diseases, though the underlying mechanisms remain unclear. We obtained HBV-
HCC
lncRNA profiles by deep sequencing and found HOTTIP to be significantly upregulated. RT-qPCR indicated that HOTTIP is highly expressed in HBV-positive hepatoma tissue and induced by HBV in vitro. Virological experiments showed that HOTTIP significantly suppresses the generation of hepatitis B viral surface antigen (HBsAg), hepatitis B viral e antigen (HBeAg) and HBV replication.
HOXA13
, a downstream factor of HOTTIP, was found to bind to HBV Enh I/Xp to repress the production of HBV pregenome RNA (pgRNA) and total RNA as well as HBV replication, suggesting that
HOXA13
mediates HOTTIP-induced suppression of HBV replication. More interestingly, HBV DNA pol binds to and stabilizes CREB1 mRNA to facilitate translation of the protein, which in turn binds to the regulatory element of HOTTIP to promote its expression. CONCLUSION: Our findings demonstrate that HBV DNA pol attenuates HBV replication via activation of the CREB1-HOTTIP-
HOXA13
axis. These findings shed light on the mechanism by which HBV restrains replication to contribute to persistent infection.
...
PMID:HBV DNA polymerase restrains viral replication via the CREB1-HOTTIP-HOXA13 axis. 3231 10